Millennium Management LLC Sells 155,270 Shares of Relx Plc (NYSE:RELX)

Millennium Management LLC lowered its stake in Relx Plc (NYSE:RELX - Free Report) by 46.0% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 181,956 shares of the technology company's stock after selling 155,270 shares during the quarter. Millennium Management LLC's holdings in Relx were worth $8,264,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in RELX. CENTRAL TRUST Co boosted its stake in shares of Relx by 1,290.2% during the 4th quarter. CENTRAL TRUST Co now owns 570 shares of the technology company's stock worth $26,000 after purchasing an additional 529 shares during the period. Transce3nd LLC acquired a new stake in shares of Relx in the fourth quarter valued at about $40,000. Sierra Ocean LLC purchased a new stake in Relx during the 4th quarter valued at about $43,000. Brown Brothers Harriman & Co. raised its stake in Relx by 218.5% during the fourth quarter. Brown Brothers Harriman & Co. now owns 965 shares of the technology company's stock worth $44,000 after purchasing an additional 662 shares during the period. Finally, Private Trust Co. NA raised its holdings in Relx by 19.2% in the 4th quarter. Private Trust Co. NA now owns 1,237 shares of the technology company's stock valued at $56,000 after buying an additional 199 shares during the period. Institutional investors own 15.02% of the company's stock.

Relx Trading Up 0.2%

NYSE RELX traded up $0.09 on Friday, hitting $54.02. 247,672 shares of the stock were exchanged, compared to its average volume of 715,774. Relx Plc has a 52-week low of $43.28 and a 52-week high of $56.33. The company has a debt-to-equity ratio of 1.46, a current ratio of 0.52 and a quick ratio of 0.47. The company has a market capitalization of $99.71 billion, a price-to-earnings ratio of 29.01, a P/E/G ratio of 2.73 and a beta of 0.86. The company's 50-day moving average price is $52.21 and its two-hundred day moving average price is $49.37.

Analyst Upgrades and Downgrades

A number of brokerages have commented on RELX. Barclays raised shares of Relx from an "equal weight" rating to an "overweight" rating in a research report on Friday, March 14th. The Goldman Sachs Group began coverage on Relx in a research note on Wednesday, March 26th. They issued a "buy" rating on the stock. Wall Street Zen cut shares of Relx from a "buy" rating to a "hold" rating in a research report on Tuesday, March 4th. Finally, Morgan Stanley reissued an "overweight" rating on shares of Relx in a research report on Wednesday, April 16th. One analyst has rated the stock with a hold rating, four have issued a buy rating and one has issued a strong buy rating to the company's stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Buy".

About Relx

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.